In SLE, MDSCs promote Th17 differentiation and exacerbate disease severity,44, 45 while in RA, they produce proinflammatory cytokines (e.g., TNF‐α, IL‐1β) and induce Th17 differentiation.46, 47, 48. This evidence concerns the gene TNF and systemic lupus erythematosus.